Americas (WHO region) vs Uzbekistan: Cases started on MDR-TB treatment
Americas (WHO region)
5,225
in 2024
Uzbekistan
2,994
in 2024
Americas (WHO region) rank
11th
Uzbekistan rank
12th
Cases started on MDR-TB treatment over time
- Americas (WHO region)
- Uzbekistan
How they compare
Americas (WHO region) currently reports 5,225 against 2,994 in Uzbekistan, a difference of 2,231.
That makes Americas (WHO region)'s figure about 1.7 times Uzbekistan's.
The two have swapped places 2 times across 16 shared years of data; in 2009 it was Americas (WHO region) ahead.
Americas (WHO region) ranks 11th and Uzbekistan ranks 12th of 11 groups.
Americas (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Americas (WHO region) | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3,161 | 464 | 2,697 | Americas (WHO region) |
| 2010s | 3,609 | 2,014 | 1,595 | Americas (WHO region) |
| 2020s | 4,846 | 2,277 | 2,570 | Americas (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Americas (WHO region) or Uzbekistan?
- Americas (WHO region), at 5,225 against 2,994 in Uzbekistan as of 2024.
- What is the difference in cases started on mdr-tb treatment between Americas (WHO region) and Uzbekistan?
- 2,231, with Americas (WHO region) ahead.
- How many years of comparable data are there for Americas (WHO region) and Uzbekistan?
- 16 years are reported by both, from 2009 to 2024.
- How do Americas (WHO region) and Uzbekistan rank globally for cases started on mdr-tb treatment?
- Americas (WHO region) ranks 11th and Uzbekistan ranks 12th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.